DEFENCE
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Interferon beta-1a
Interferon alpha/beta receptor agonist
What it measured
Main measures
Evaluate RNFL thickness changes in early RRMS patients treated with two different dosages of IFN beta 1a at 12 and 24 months of treatment
Retina scans (OCT)
Who could take part
Relapsing MS
Inclusion: oRR-MS diagnosis according to the revised Mc Donald criteria Exclusion: oPrimary or secondary progressive MS
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
To demonstrate whether Retinal Nerve Fiber Layer (RNFL) as measured by Optical Coherence Tomography (OCT) is able to show IFN beta 1a dose-response axonal loss in early RRMS patients.
Loading reviews and guidelines…
Related trials
- TWINS
Phase 3 · Not yet recruiting
Still running
- Pregnancy Exposure Registry for Vumerity (Diroximel Fumar…
Recruiting
Still running
- Full Responders
Phase 4 · Stopped early
Stopped early
- A Study to Learn More About The Safety of Diroximel Fumar…
Running, not recruiting
Still running
- Study to Investigate Pregnancy Outcomes in Female Partici…
Completed
Result in a paper, not read yet
- 105MS306
Phase 3 · Running, not recruiting
Still running
History
Started
Oct 2009
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error